Q1 FY27 loss at Rs 3.91 lakh, revenue drops about 90% YoY

Revenue DeclinePat NegativeResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.1%Reaction day

₹35.14

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+0.9% vs market

Other Agricultural Products peers, median of 56sector-0.6%+1.7% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.7 pts more than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.1+0.2+0.9-0.6+1.7

Next day

+1.1+0.2+0.8-0.2+1.3

+3.1+0.4+2.7+0.0+3.1

+5.1+0.7+4.4-0.6+5.7

+7.2+0.1+7.0-1.7+8.9

+5.0+0.7+4.3-0.6+5.5

+1.8+1.2+0.7-0.5+2.4

15d

+10.2+0.7+9.5+0.0+10.2

+12.0-1.2+13.2-0.6+12.6

+7.0-1.1+8.2-0.3+7.3

—————

UpDownMarket · Nifty Microcap 250Sector · Other Agricultural Products peers, median of 56Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 (June 2026) unaudited results. Total income fell to Rs 0.89 lakh from Rs 8.96 lakh YoY, about a 90% drop. Loss for the quarter widened to Rs 3.91 lakh from Rs 2.36 lakh YoY. Auditor gave an unmodified opinion. Board also re-appointed internal auditor M/s Suraj Rajput & Co for FY 2026-27 and Mr. Aditya Sharma as independent director for a second 5 year term (2026-27 to 2030-31), subject to shareholder approval.

Likely market impact

Continued losses and sharp revenue fall remain a concern for shareholders; governance re-appointments are routine.